From Fatty Liver to Non-alcoholic Steatohepatitis: The Cause of Dramatic Disease Progression Discovered

被引：0
|
作者：
不详
机构：
来源：
DIABETOLOGIE UND STOFFWECHSEL | 2021年 / 16卷 / 05期
关键词：
D O I：
10.1055/a-1591-7717
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：368 / 368
页数：1
相关论文
共 50 条
  • [31] NASH (Non-Alcoholic Steatohepatitis): Fatty Liver or Fatal Liver Disease?
    Roeb, E.
    ZENTRALBLATT FUR CHIRURGIE, 2014, 139 (02): : 168 - 174
  • [32] Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis
    Lirussi, F.
    Azzalini, L.
    Orando, S.
    Orlando, R.
    Angelico, F.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (01):
  • [33] Bile acids for non-alcoholic fatty liver disease and/or steatohepatitis
    Orlando, R.
    Azzalini, L.
    Orando, S.
    Lirussi, F.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (01):
  • [34] Clinical update on non-alcoholic fatty liver disease and steatohepatitis
    Bugianesi, Elisabetta
    Bellentani, Stefano
    Bedogni, Giorgio
    Tiribelli, Claudio
    Svegliati-Baroni, Gianluca
    Croce, Lory S.
    Gastaldelli, Amalia
    Marchesini, Giulio
    Marra, Fabio
    Perseghin, Gianluca
    Tell, Gianluca
    ANNALS OF HEPATOLOGY, 2008, 7 (02) : 157 - 160
  • [35] S100A9: A Potential Biomarker for the Progression of Non-Alcoholic Fatty Liver Disease and the Diagnosis of Non-Alcoholic Steatohepatitis
    Liu, Xiaolin
    Wang, Yongfeng
    Ming, Yanan
    Song, Yanyan
    Zhang, Jingyi
    Chen, Xiaoyu
    Zeng, Minde
    Mao, Yimin
    PLOS ONE, 2015, 10 (05):
  • [36] Natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: a longitudinal assessment of severity, progression, and risk Factors
    Nordstrom, Beth
    Simeone, Jason
    Hoogwerf, Byron J.
    Li, Qian
    Haupt, Axel
    Ali, Ayad K.
    Boardman, Marilyn K.
    Bae, Jay
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 292 - 292
  • [37] Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis
    Angelico, F.
    Burattin, M.
    Alessandri, C.
    Del Ben, M.
    Lirussi, F.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (01):
  • [38] What Does the Future Hold for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis?
    Doumas, Michael
    Imprialos, Konstantinos
    Stavropoulos, Konstantinos
    Athyros, Vasilios G.
    CURRENT VASCULAR PHARMACOLOGY, 2019, 17 (05) : 425 - 428
  • [39] Pleiotropic Effects of Statins in the Light of Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
    Ahsan, Farah
    Oliveri, Federico
    Goud, Harshit K.
    Mehkari, Zainab
    Mohammed, Lubna
    Javed, Moiz
    Althwanay, Aldanah
    Rutkofsky, Ian H.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (09)
  • [40] The Role of Interferon Regulatory Factors in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
    Zhang, Chunye
    Liu, Shuai
    Yang, Ming
    GASTROENTEROLOGY INSIGHTS, 2022, 13 (02) : 148 - 161
12345